Therapeutic alliance in two treatments for adolescent anorexia nervosa. by Forsberg, Sarah et al.
UCSF
UC San Francisco Previously Published Works
Title
Therapeutic alliance in two treatments for adolescent anorexia nervosa.
Permalink
https://escholarship.org/uc/item/8xs6759q
Journal
The International journal of eating disorders, 46(1)
ISSN
0276-3478
Authors
Forsberg, Sarah
LoTempio, Elizabeth
Bryson, Susan
et al.
Publication Date
2013
DOI
10.1002/eat.22047
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Therapeutic Alliance in Two Treatments for Adolescent
Anorexia Nervosa
Sarah Forsberg, MS1*
Elizabeth LoTempio, MS1
Susan Bryson, MA, MS2
Kathleen Kara Fitzpatrick, PhD2
Daniel Le Grange, PhD3
James Lock, MD, PhD2
ABSTRACT
Objective: The aim of this study was to
examine the relationship between thera-
peutic alliance and treatment outcome
(remission status) in family-based treat-
ment (FBT) and adolescent-focused ther-
apy (AFT) for adolescents with anorexia
nervosa (AN).
Method: Independent observers rated
audiotapes of early therapy sessions
using the Working Alliance Inventory-
Observer Version (WAI-o). Outcome
was defined using established cut-
points for full and partial remission.
To control for effects of early symp-
tom improvement, changes in weight-
and eating-related psychopathology
prior to the alliance session were cal-
culated and entered as a covariate in
each analysis.
Results: Participants in AFT had signifi-
cantly higher alliance scores; however, over-
all scores were high in both therapies. The
alliance was not a predictor of full remis-
sion for either treatment, though it was a
non-specific predictor for partial remission.
Discussion: Therapeutic alliance is
achievable in adolescents with AN in
both AFT and FBT, but demonstrated no
relationship to full remission of the dis-
order. VC 2012 by Wiley Periodicals, Inc.
Keywords: anorexia nervosa; therapeutic
alliance; adolescents; family-based treatment
(Int J Eat Disord 2013; 46:34–38)
Introduction
Clinicians report challenges in developing a thera-
peutic alliance with patients with AN. This may
result in part because of the ego-syntonic nature of
the disorder.1 Nonetheless, studies of therapeutic
alliance in psychosocial treatments for most child
and adolescent disorders suggest that alliance is
likely as important for younger patients as it is for
adults.2 However, challenges to developing thera-
peutic alliance may be even greater when working
with children and adolescents with AN because
they are usually brought to treatment by their
parents, deny there is a problem with their behav-
iors or thinking, are often treated in a family con-
text, and often do not trust adults’ ability to under-
stand their concerns.3 Only two previous studies
have explored the relationship between therapeutic
alliance and treatment outcome for adolescents
with eating disorders. No association between ther-
apeutic alliance and outcome was found in a study
comparing individual supportive psychotherapy
(SFT) and family-based treatment (FBT-BN) in ado-
lescents with bulimia nervosa (BN), but more
severe symptoms at baseline was associated with
poorer alliance in FBT.4 In a study of adolescents
with AN, who received different doses of FBT, early
behavioral change (weight gain) rather than alli-
ance predicted outcome. However, greater parental
alliance early in treatment improved treatment
retention.5
In order to better understand the role of thera-
peutic alliance in treatment of adolescents with an-
orexia nervosa (AN), we compared the relationship
between early therapeutic alliance and outcome in
manualized individual therapy (adolescent-focused
therapy—AFT) and manualized family therapy
(family-based treatment—FBT) using audiotaped
therapy sessions from a large randomized clinical
trial (RCT) of adolescents treated for AN.6 For the
purposes of this study, therapeutic alliance was
defined using Bordin’s pantheoretical conceptuali-
zation, encompassing both collaborative elements
(engagement and agreement on tasks and goals of
therapy) as well as the interpersonal bond between
the patient and the therapist.7 Our primary hypoth-
esis was that early therapeutic alliance scores
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would be higher in AFT compared to FBT, as AFT
particularly focuses on developing early alliance as
part of treatment while FBT does to a lesser extent.
However, because previous studies did not suggest
that alliance was a predictor of outcome in adoles-
cent eating disorders, we hypothesized that, based
on type of treatment, early alliance would not have
a differential effect on clinical remission at the end
of treatment (EOT).
Method
This study was approved by IRB’s at both universities
(Chicago and Stanford) where participants were enrolled.
Participants
Participants in the current study were a subsample
drawn from a multi-site RCT (N 5 121) for adolescents
with AN. To be eligible for the original RCT, participants
met criteria for DSM-IV AN except for the requirement of
amenorrhea. Individuals were excluded if they had co-
morbid diagnoses of psychosis, drug, or alcohol depend-
ence, were acutely suicidal, or were medically unstable
according to published criteria. Participants were
randomly assigned to either FBT or AFT.
To examine the relationship of therapeutic alliance
measured early in treatment to outcome, we restricted
our sample of tapes to those who had audible recordings
of therapy at Sessions 3, 4, or 5, and who completed EOT
assessment (N 5 78). Our final therapeutic alliance par-
ticipant sample was 91% female; 76% were White, 13%
were Asian, 5% were Hispanic, 5% were Biracial, and 1%
were African American. Mean duration of illness was 10.6
months (SD 5 7.7), and 21% of participants had a co-
morbid psychiatric diagnosis. At time of Baseline (BL)
assessment, the average percent expected body weight
(%EBW) of the sample was 80.7% (SD 5 3.6%) and the
mean global eating disorder examination (EDE) score
was 1.7 (SD5 1.4).
We compared the alliance sample (N 5 78) to those
remaining in the original sample but were treatment
dropouts (N 5 21), as well as to those who were missing
tapes or other data (N 5 22). Pair-wise comparisons for
each group using the Kruskal–Wallis one-way analysis of
variance, adjusting the p-value to account for multiple
analyses (p \ .017) were conducted. The three groups
were compared on the following variables: BL %EBW, BL
EDE scores, BL BMI percentile, duration of illness, age,
and total therapy minutes. Categorical demographic
variables (gender and ethnicity) and psychiatric co-mor-
bidity were examined using the chi-square test.
Based on these analyses, participants in the alliance
sample did not differ from the original sample on any
measures examined, except for number of therapy
minutes, with those who dropped from treatment having
significantly less time in treatment (p\ .001).
Additionally, we compared BL differences in the alli-
ance sample by treatment group. Those in AFT had sig-
nificantly lower BL BMI percentiles than individuals in
FBT (p 5 .025) and higher BL EDE scores (p 5 .006); thus,
these differences were controlled for in all subsequent
analyses (see description of factors obtained from a prin-
ciple components analysis below).
Treatments
Family-Based Treatment. The form of family therapy
used in this study was manualized FBT. In FBT, the focus
is on parental management of maintaining behaviors
(severe caloric restriction, excessive exercise, purging
behaviors) that perpetuate extreme low weight. FBT has
three stages.8 In the first stage, parents are charged with
the task of helping their child restore weight. During the
second phase, control over eating is gradually returned to
the adolescent by the parents. Phase three shifts away
from food and eating to target developmental issues
around adolescence as well as relapse prevention and
termination.
Adolescent-Focused Therapy. The form of individual
therapy used in the study is manualized AFT. AFT is
based on a self-psychology model.9 In this model, the
focus is directed toward the ways in which AN serves to
protect an individual from negative affect and conflict
around developmental challenges. The model focuses on
increasing self-awareness and facilitating self-efficacy
wherein the patient–therapist relationship is hypothe-
sized to be the primary mechanism of change. AFT has
three phases. The first phase focuses on building rapport
and exploring the ways AN serves to distract the patient
from stressful affective experiences. The second phase
examines issues of development and individuation. The
third phase promotes developing alternative strategies to
manage stress, and involves problem solving around
potential future difficulties typically associated with
adolescence.
Measures
Working Alliance Inventory. The Working-Alliance
Inventory (WAI) was first developed by Horvath and
Greenberg (1989) and was transformed into an observer-
version by Tichenor and Hill (1989).10,11 Each component
of the alliance (agreement on tasks, agreement on goals,
and affective bond) is represented by 12-items which can
be examined at the subscale level, or can be combined to
provide a general alliance score. Items are rated on a
Likert scale ranging from 1 (never, or no agreement/indi-
cation of agreement on tasks and goals/affective bond)
to 7 (always, or full agreement on tasks and goals/strong
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affective bond). The WAI is one of the most frequently
used instruments in the therapeutic alliance literature,
and has been shown to have good internal validity, test-
retest reliability and inter-rater reliability.12
Eating Disorder Examination. The EDE (version 12.0) is
a structured clinical interview assessing for varying levels
of eating disorder pathology.13 Change in restraint over
eating early in treatment was assessed during Sessions
1,2, 4, 6, and 8 using a single question from the EDE.
Weight. Heights and gowned weights for participants
were obtained at BL, weekly (ungowned) at each treat-
ment session thereafter, and at EOT.
Rater Training
Two graduate-level clinical psychology students, who
were otherwise not involved in the original RCT, con-
ducted therapeutic alliance ratings of all available partic-
ipants. Raters were trained to use the WAI-o.6 Tapes were
assigned to each rater using a random numbers table to
increase variability of treatment condition, site, and ther-
apist, within each rater. Each rater also rated ten of the
same tapes to examine interrater reliability (IRR). Ratings
were coded for interactions between the therapist and
identified patient in both therapies. Raters used a bench-
mark of ‘‘4’’ (no evidence for/equal evidence for and
against), rating up or down as information was collected.
If a tape was inaudible, or Session 4 was missing, raters
attempted to rate the next closest audible session (either
Sessions 3 or 5). Session 3 was selected first, as studies
suggest that alliance measured early in treatment is typi-
cally a better predictor of outcome, and when Session 3
was unavailable, Session 5 was rated instead.7 If all of
these sessions were either inaudible or unavailable, the
individual participant was excluded from the study. IRR
was calculated as r 5 .88 using Spearman’s correlations.
Data Analysis
In the original RCT, the primary outcome of full remis-
sion was defined a priori as those individuals meeting a
minimum of the 95th percentile of mean body weight for
age, height, and gender using Center for Disease Control
(CDC) norms, and achieving a score on the EDE within 1
SD of globally published norms (M 5 1.59). Partial remis-
sion, defined as greater than the 85th percentile of mean
body weight for age, height, and gender using CDC norms
was examined as a secondary outcome. For the purposes
of our analyses, significance values used throughout the
study were set at .05, and all tests were two-tailed. Data
were checked for normal distribution and non-parametric
tests were used when samples were not normally distrib-
uted.
To examine whether therapeutic alliance was a predic-
tor of full remission status (as defined above), and
whether predictive power of alliance differed by treat-
ment group, we conducted a binary logistic regression.
The categorical dependent variable was full remission
status at EOT (coded 1 5 yes, 0 5 no). We controlled for
early change (before the measured alliance session) in
these variables as well as BL differences in weight and
eating disorder symptomology using factors generated
from a principal components analysis. Factor 1 (BL BMI
percentile and early full remission status) and Factor 2
(BL EDE and early change in restraint) were entered at
Step 1 of the regression model. The centered mean thera-
peutic alliance scores, coded treatment (AFT 5 20.5,
FBT5 0.5), and the computed treatment3 alliance inter-
action term were entered as predictors at Step 2.
We repeated the primary logistic regression analy-
ses using partial remission status (coded 1 5 yes, 0 5
no) as the outcome variable. In this analysis, BL dif-
ferences in weight and early change in weight were
controlled for as the definition of partial remission
only involves weight criteria. Factor 3 (BL BMI per-
centile and early partial remission status) was entered
as a covariate at Step 1. The centered mean therapeu-
tic alliance score, coded treatment (20.5, 10.5), and
the treatment 3 Alliance Interaction were entered
simultaneously at Step 2.
Results
Alliance Scores
We compared mean alliance scores (global, task,
goal, and bond scores) by treatment group using
independent sample T tests. Participants in AFT
had significantly higher alliance scores on all
scales. Effect sizes measured between the two treat-
ment arms on measures of alliance were large, by
Cohen’s standards (total alliance: AFT M 5 5.31
(0.67), FBT M 5 4.25 (0.99), d5 1.26, p\ .001).
Full Remission
At EOT, 14 (36.8%) of participants met full remis-
sion criteria in FBT and 9 (22.5%) in AFT. The rate
of full remission status in FBT in this subsample is
lower than that found in the original study (42%),
but nearly equivalent to rates of the original study
in AFT (23%). Results of the regression demon-
strated no main effect or interaction effect for
alliance on outcome (Table 1).
Partial Remission
At EOT, 27 (67.5%) in AFT and 34 (89.4%) in FBT
met a minimum of partial remission criteria. These
rates of partial remission are similar to those found
in the original study for both treatments. Results of
the regression demonstrated that the total alliance
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score was predictive of outcome (p 5 .021). A unit
increase in alliance score resulted in an increase in
the odds of being partially remitted by weight
([85%) by a factor of 3.32. However, there was no
significant interaction between alliance and treat-
ment type on outcome (Table 1).
Discussion
As predicted, we found significantly greater thera-
peutic alliance ratings in AFT. Also as hypothesized
there was no main effect or interaction effect for
alliance on full remission. However, results suggest
that alliance was a significant non-specific predic-
tor of partial remission.
Findings from this study are best interpreted in
light of important limitations. It is a secondary
analysis of results from an RCT designed to test
differences in remission rates between two active
treatments. Addressing the nuances of the alli-
ance–outcome relationship is complex and a fur-
ther understanding of the relationship among ado-
lescents with AN would benefit from a careful ex-
amination of how the alliance develops over time.
Thus, it is not possible to assess the relationship
between the alliance and symptom change prior
to Sessions 3, 4, or 5 or later in therapy. We did not
identify other studies that measured alliance ear-
lier than the second session. Therefore, our meth-
odology was consistent with the majority of previ-
ous studies measuring early alliance around the
3rd or 4th session of treatment and controlling for
change prior to the alliance session. By measuring
alliance around Session 4, our goal was to measure
it early enough that the majority of symptom
change had not yet occurred, but there was
enough time to develop a relationship. However,
in our sample, even within the first month of treat-
ment 35% of change in weight (BMI percentile)
had occurred in both treatment arms, suggesting
that it may be necessary in future studies to look
at the alliance even earlier in treatment. Nonethe-
less, we controlled for this change prior to mea-
surement of the alliance session to prevent this
potential confound in illuminating the direction of
the alliance–outcome relationship.14 In addition,
while research suggests that observer ratings may
be less subject to bias and are as effective at pre-
dicting outcome as therapist and participant rat-
ings, understanding of the alliance in AN may be
improved by including therapeutic alliance ratings
made by participants and therapists in future
studies.12,15
These results have several potentially important
implications for future treatment alliance research,
specifically in the context of adolescent AN. The
sample we examined did not appear to have sys-
tematic biases. The assessments of therapeutic alli-
ance were made independent of clinicians and par-
ticipants, and without knowledge of outcomes. The
measure of therapeutic alliance used is considered
the gold standard. In addition, the data analysis
controlled for baseline differences as well as any
symptomatic change related to outcome (EDE and
weight) prior to therapeutic alliance assessment
thereby mitigating any effects of early treatment
response in the analysis.
Consistent with expectations, alliance was
effectively established in AFT and superior to that
established in FBT. However, the benefits of a good
therapeutic alliance in FBT did not lead to better
outcomes, nor did the lack of a strong alliance in
FBT appear to negatively affect outcomes. The cur-
rent study fills an important gap in the alliance–
outcome literature. Few studies have examined the
alliance among adolescents with AN, and further,
none have compared its impact on outcome in two
active treatments. Our findings suggest that even
among adolescents with AN, a group who may
present with characteristics that implicate possible
challenges in developing an alliance, a strong alli-
ance is achievable. Therefore, consistent with DeR-
ubeis and coworkers view on the varying role that
common factors like the alliance may play in differ-
ing treatments, it appears that among adolescents
with AN, a strong therapeutic alliance may be
important in establishing the context for treatment
TABLE 1. Logistic regressions for treatment outcome
measures
Predictors OR 95% CI df P
Predictors of full remission
Constant 0.38 1 .005
Factor 1 2.24 [1.24, 4.05] 1 .007**
Factor 2 1.03 [0.56, 1.88] 1 Ns
Alliance: Total score 1.54 [0.69, 3.45] 1 Ns
Treatment 1.42 [0.36, 5.66] 1 Ns
Treatment3 alliance interaction 1.46 [0.29, 7.31] 1 Ns
Predictors of partial remission
Constant 12.89 1 \.001
Factor 3 4.73 [1.80, 12.46] 1 .002**
Alliance: Total score 3.32 [1.20, 9.20] 1 .02*
Treatment 19.04 [1.72, 210.87] 1 .02*
Treatment3 alliance Interaction 2.74 [0.40, 18.85] 1 Ns
Notes: OR 5 odds ratio; CI 5 confidence interval; df 5 degrees free-
dom; Factor 1 5 baseline BMI%ile and early full remission by weight; Fac-
tor 2 5 baseline EDE and early change in restraint; Factor 3 5 BL BMI%ile
and early partial remission status; full remission 5[95% expected body
weight and Eating Disorder Examination scores within 1SD of community
norms; partial remission5[85% expected body weight; ns5 non-signifi-
cant; * p\ .05; ** p\ .01.
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success, but is not sufficient on its own to produce
meaningful clinical change.16
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